Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

China’s COVID vaccines are going global — but questions remain

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 593, 178-179 (2021)


Updates & Corrections

  • Update 12 May 2021: This story was updated to include the news that on 7 May, the World Health Organization listed Sinopharm’s Beijing vaccine and reported an efficacy of 79%.


  1. Victora, C. G. et al. Preprint at medRxiv (2021).

Download references


Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links